NARA — Pangenomic Health Cashflow Statement
0.000.00%
Last trade - 00:00- CA$10.28m
- CA$10.45m
Annual cashflow statement for Pangenomic Health, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.65 | -12 | -2.97 | -3.8 | -3.43 |
| Depreciation | |||||
| Non-Cash Items | 1.83 | 8.98 | 0.212 | 2.5 | 1.23 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.244 | 0.225 | 1.18 | 1.24 | 0.321 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -1.06 | -2.78 | -1.57 | -0.058 | -1.88 |
| Capital Expenditures | -0.007 | -0.006 | -0.003 | 0 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.598 | -0.046 | 0 | — | — |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.605 | -0.052 | -0.003 | 0 | — |
| Financing Cash Flow Items | 0 | — | — | — | -0.006 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.97 | 1.57 | 1.5 | 0.047 | 1.92 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.31 | -1.26 | -0.076 | -0.011 | 0.037 |